code J3488. (Injection, Zoledronic Acid (Reclast), 1 mg) will be replaced with HCPCS code Q2024 effective. J. The status indicators
Primary code: M89.9 or M94.9 plus Z85.46. Prevention of bone loss in breast cancer. Primary code: M89.9 or M94.9 plus: Z85.3. Reclast. ICD-10.
J3247: Permanent J-code for the IV formulation of COSENTYX Effective J, for all sites of care. If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code J3590.
J3247: Permanent J-code for the IV formulation of COSENTYX Effective J, for all sites of care If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code J3590.
Fee schedules, relative value units The following ICD-10-CM codes support medical necessity and provide coverage for HCPCS code: J3489 (Reclast).
J-. N)) LCntrctr=3711 DocType=Active bc=AgACAAIAIAAAAA%3d%3d . Page 50 ➢ Code for Reclast was substituted for New HCPCS code J3489. ➢ For Zometa
Under the Healthcare Common Procedure Coding System (HCPCS), the BRIUMVI J-Code (J2329) will become effective J. J-Code for BRIUMVI
If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code, J3590. It is the sole responsibility of the
Clinical Criteria. HCPCS or CPT Code(s). Drug ; ING-CC-0019. J3489. Reclast, Zometa
R.